Sponsorship and Funding
Sponsorship
The International League Against Epilepsy is a medical association comprised of physicians, basic scientists and other health care professionals. Our mission is to provide members with the educational and research resources that are essential in understanding, diagnosing and treating persons with epilepsy. We accept sponsorship from pharmaceutical companies, medical product companies and other health related organizations, provided sponsorship adheres to ILAE rules in terms of transparency and ethical code.
Through our international and regional congresses, workshops and other programs, sponsors are provided with the opportunity to:
- Present new clinical data and product information to a targeted customer base
- Support epilepsy education through unrestricted educational grants
- Demonstrate commitment to improving the quality of life for people with epilepsy
2024 Funding Sources

Industry related income is 21.4% of overall income, and non-industry related income is 78.6%.
The largest contribution by one particular company is 2.8% of overall income.
2024 Sponsors
- AIT Austrian Institute of Technology GmbH
- ALCIS
- Aleft Medical
- Angelini Pharma
- Bago Labs
- BESA GmbH
- Biocodex
- Biohaven
- Bodega Farma
- Cadwell
- Camilo Labs
- CEREBRO SPAIN BIDCO S.L.
- Clouds of Care NV
- Compumedics
- Compumedics Europe GmbH
- DESITIN Arzneimittel GmbH
- DIXI medical
- EB Neuro S.p.A.
- Eisai
- Empatica
- EMS Biomedical
- Jazz Pharmaceuticals
- Lam
- Liv Assured (NightWatch)
- LivaNova Deutschland GmbH
- LivaNova PLC
- Longboard
- Medevolve
- Megalabs
- MEGIN OY
- Mitotherapies
- Natus Medical Inc
- Neurogen
- Neuroventis
- Neurovirtual
- Nutricia
- Orion
- Persyst Development Corp.
- Praxis Precision Medicines, Inc
- SMART Grupo Mallen
- Stoke Therapeutics
- Sued & Fargesa
- Syngap
- Takeda
- UCB Pharma
- UNEEG medical
- UniQure
- Xenon Pharma
- X-System Limited
2023 Funding Sources

Industry related income is 18% of overall income, and non-industry related income is 82%.
The largest contribution by one particular company is 7.7% of overall income.
2023 Sponsors
- Ad-Tech Medical Instrument Corporation
- Angelini Pharma
- BESA GmbH
- Biocodex
- Biohaven
- BioMarin
- BioSerenity, Inc.
- Brainlab Sales GmbH
- Byteflies NV
- Clouds of Care NV
- Compumedics Europe GmbH
- Desitin Arzneimittel GmbH
- DIXI medical
- EB Neuro S.p.A.
- Eisai
- Jazz Pharmaceuticals
- Kephala Ltd
- Liv Assured (NightWatch)
- LivaNova PLC
- Medtronic International Trading Sàrl
- MEGIN Oy
- Natus Medical
- Neuraxpharm Ireland Ltd.
- Neuroventis
- Nihon Kohden Europe GmbH
- Persyst Development Corp.
- Stoke Therapeutics
- Takeda
- UCB
- UNEEG medical
- vCreate
- X-System Limited
2022 Funding Sources

Industry related income is 36% of overall income, and non-industry related income is 64%. The largest contribution by one particular company is 7.7% of overall income.
2022 Sponsors
- Ad-Tech Medical Instrument Corporation
- Angelini Pharma
- BESA GmbH
- Biocodex
- BioMarin Oharmaceutical Inc
- Brainlab
- Compumedics
- Danone
- Deep Breath Intelligence AG
- Desitin Arzneimittel GmbH
- DIXI medical
- Eisai
- Epilog NV
- G.S.A.R. Marketing, SL
- HempMeds Mexico SA de CV
- Instrumentacion SA
- Jazz Pharmaceuticals
- John Libbey Eurotext
- Labortorios Biopas SA
- LivaNova
- Medtronic
- Micromed
- MITO THERAPIES S A S
- Natus Medical Incorporated
- Neurelis, Inc.
- Neuro Events Labs
- Neuroventis BV
- Neurovirtual USA Inc
- NightWatch
- Nihon Kohden
- Orion Pharma
- Persyst Development Corporation
- PTC Therapeutics
- Ripple
- RP Médicas SA
- Savoy Foundation
- Seer Medical
- Takeda Pharmaceuticals
- Tecnofarma Colombia SAS
- UCB Biopharma SRL
- UNEEG Medical A/S
- vCreate Ltd
- WamaPharma SAS
- Xenon Pharmaceuticals
- Zogenix
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community